Cannabis oil coffee shop and hotel opens in Colchester today



Cannabis oil coffee shop and hotel opens in Colchester today


St Botolph's Circus


A new coffee shop and boutique hotel offering CBD and hemp products is set to open in Colchester.

Green Coffee Lab launches today in St Botolph’s Circus.

The new cafe will offer coffees, teas and vegan food infused with CBD and hemp as well as cocktails and sweets.

Eight rooms are also on offer for rental in a hotel.

It is believed to be the first CBD hotel in the country. 

CBD is a cannabinoid derived from the cannabis plant used for medicinal purposes.





Has legal cannabis killed the bong?



Has legal cannabis killed the bong?


Under cannabis prohibition, nothing signified one’s love of the plant more than bongs – but health-conscious users who prefer to vape don’t have much use for them


‘To the fraternity of underground cannabis users, they were akin to sacred totems.’


The Guardian


n the stoner culture that flourished under cannabis prohibition, nothing signified one’s love of the plant more clearly than the water pipes known as bongs. This was for practical as well as symbolic reasons. Bongs offer more smoke and a smoother hit than pipes or joints. Whether in use or not, they convey a clear message: marijuana is smoked here.


They have been used to smoke cannabis since antiquity. When someone is sucking on a bong, mouth agape inside a glass tube, it’s a pose of the purest hunger, like a baby goat sucking on an udder. Users often named their bongs. To the fraternity of underground cannabis users, they were akin to sacred totems.

But with legalization under way, bongs have an image problem. The “wellness”-obsessed cannabis industry doesn’t have much use for them. Health-conscious users prefer to vape or eat cannabis than combust it. The bong as centerpiece of a room also isn’t a good fit for the industry’s new ethos, echoed in the slogan of the magazine Gossamer: “For people who also smoke weed.”

Simultaneously, the heaviest cannabis users have gravitated away from flower to stronger THC concentrates that they consume with dab rigs, contraptions that can look like bongs but are used to vaporize the drug with the help of a blow torch. Popular new products such as the PuffCo Peak and Vapexhale look like bongs and can be called bongs, but they are vaporizers, not pipes.


Even so, smoking accessories remain a sizable industry. In 2013, US head shops generated $10bn in revenue, about the same size as the 2018 legal US cannabis market.

Harrison Baum, CEO of Daily High Club, an online head shop that sends a monthly box of smoking accessories to subscribers, said today bongs were “a niche, but a very big niche”, popular with younger people and nostalgists in their 50s and 60s reliving their college days.

In four years, Baum said, the company had sold more than 300,000 bongs. Popular models include the “southern dabber”, which features a dab rig’s smaller chamber inside a bong chamber, and the “road rasta”.



In the early days of the green rush, Jane West, an event planner and mom in suburban Denver, made a name for herself throwing upscale pot parties, at least one of which featured a working bong ice sculpture. Today she has released a line of smoking accessories, including a glass bong called a “beaker” that would look at home on a tastefully appointed shelf next to a wine decanter. Its chamber is meant to approximate a person’s lung capacity.

Meanwhile, upscale head shops have popped up in places like the Los Angeles branch of the swank department store Barney’s.

There’s a parallel with sex toys. Once hidden behind counters, they now boast serious design credentials and can be bought in attractive shops, with chipper attendants happy to “educate” consumers about their various properties. And a community of glass workers has elevated elaborate bongs into a form of folk art, with pieces by well-known artists selling for more than $10,000.

So, yes, the bong is gentrifying. And it may always have its fans – as West says: “There’s nothing that compares.”



Kids who vape weed are ‘more likely to be thieves and violent thugs’



Kids who vape weed are ‘more likely to be thieves and violent thugs’


Scientists fear weed has bad effects on teenagers' behaviour (Picture: Getty)


Cannabis has a reputation for making its users relaxed to the point of incapacitation. But it turns out that teens who ‘vape’ the herb face a ‘significantly higher risk’ of falling into a life of crime and delinquency. In the olden days, potheads were forced to roll monster spliffs, load up a bong or bake some space cakes to get stoned. Now they can use tiny vaporizer devices to blast their brains with cannabis without generating the clouds of smelly smoke generated by traditional methods of marijuana ingestion. A team from the University of Texas has just published a piece of research exploring ‘adolescent vaping and its association with delinquency among 8th and 10th-grade students across the nation’. The research examined the use of vaporizers to take tobacco as well as weed. Criminal justice professor Dylan Jackson said: ‘Our hope is that this research will lead to the recognition among policymakers, practitioners, and parents that the growing trend of adolescent vaping is not simply “unhealthy” – or worse, an innocuous pastime – but that it may, in fact, be a red flag or an early marker of risk pertaining to violence, property offending, and other acts of misconduct.’



Smoking joints is falling out of fashion as people swap to vapes (Image: Getty)



Jackson’s research suggested that youngsters who vape are more likely to engage in violent crime, join a gang, vandalise school property, bring a weapon into the classroom or run away from home. In a statement, the university wrote: ‘These findings might be explained by the ability to conceal an illegal substance through the mechanism of vaping, which can reduce the likelihood of detection and apprehension among youth who vape illicit substances and thereby embolden them to engage other delinquent behaviours. ‘Youth who vape illicit substances such as marijuana may easily go unnoticed and/or unchallenged due to the ambiguity surrounding the substance they are vaping and the ease of concealability of vaping devices, which can look like a flash drive.’ The authors called for more work to be done to understand ‘this dangerous new drug trend’. In the report, they wrote: ‘The findings suggest that there may be something criminogenic about vaping among adolescents, but that the strength of the relationship between vaping and delinquency is contingent on what is being vaped, with marijuana vaping being most heavily correlated with delinquency.’




‘You couldn’t make it up’ – Hotel staff raised the alarm over this teenager having cannabis in his locker



‘You couldn’t make it up’ – Hotel staff raised the alarm over this teenager having cannabis in his locker


Grant North has been told to ‘grow up’ following the offence





Cannabis user Grant North was rumbled by hotel staff after keeping drugs in his locker while he went for a swim.



Stoke-on-Trent Crown Court heard how the 19-year-old was on a suspended prison term when he turned up at Festival Park’s Moat House to use the pool.

But suspicions were raised that he had cannabis in the locker and the substance was later discovered.

Now North has been told to ‘grow up’ by a judge.


He had previously appeared in court for offences relating to cannabis and had been given a suspended jail term.


Stuart Muldoon, mitigating, said: “He’s still only 19 and when, he got the suspended sentence, his life was different. He was less mature than he is now and was a heavy user of cannabis.”


North, of Bank End, Brown Edge, pleaded guilty to possession of cannabis on April 3.

Addressing Mr Muldoon, Judge David Fletcher said : “You couldn’t make it up – he’s at a health facility with cannabis in his locker. He’s 19, he’s not a child and it’s about time he grew up.”


The defendant was told to pay £340 in costs, a £75 fine, and will be under a 7pm until 5am curfew for eight weeks.



WATCH: Hundreds of cannabis plants found inside old Black Country pub



WATCH: Hundreds of cannabis plants found inside old Black Country pub


Police found a cannabis factory hidden inside an old, disused pub in Tipton.





Officers were alerted by the fire service to the scene at the Red Lion pub in Park Lane West on Tuesday night.

Around 200 plants were recovered.





An officer from Tipton Town took to Twitter to share a video of the find.

In it he said: “Here we are at The Red Lion pub in Park Lane West, Tipton.

“It’s a disused pub, has been for a while now, and as you can see it has been used to grow cannabis plants.”



He estimated there were “probably a couple of hundred” plants currently being bagged up.

The officer then moved on to another room, which was filled with pots full of soil, adding: “There were a few hundred in this room, which have now been removed and bagged up.”

West Midlands Police have said enquiries are ongoing.

Anyone with information is asked to contact police via Live Chat at between 8am and midnight, or call 101 anytime. Quote log number 2903 of May 28.


vid on link



Blurred Lines: Why is the UK now Europe’s Cocaine Capital?



Blurred Lines: Why is the UK now Europe’s Cocaine Capital?


By the time Craig Strippel found himself at the end of the Albert Pier in Penzance last October, willing his frozen legs to step onto thin air, he had lost control. Cocaine had taken over his brain. After 17 years of use, the drug had hijacked the chemical pathways that would normally have steered Craig towards the things that make life worth living. It had robbed him of his ability to assess risk and exercise self-control, the brakes that might have slowed his descent into addiction. It had burrowed deep into the primitive parts of his brain that summon emotions and memories, to provide constant reminders of just how good cocaine made him feel, like a bell that never stopped ringing.



Three hundred miles away, in London, a man we’ll call Ian was wondering whether his own relationship with cocaine was becoming something of a problem. They’d been seeing each other on and off for the best part of two decades, though Ian wasn’t as loyal as Craig: he was as enamoured of ketamine and had dalliances with MDMA and GHB. Now, following a period of unexpected job insecurity, things were starting to slide. He was using more during the week. He was, on occasion, using it alone. It worried him, but he was confident that, with a bit of effort, he could wrest back control.


Cocaine has long been Britain’s illegal stimulant of choice. The drug of Britpop benders and Met Bar toilets remains our favourite way to get buzzed. For a while, it looked as though its crown was slipping: between 2008 and 2013, the number of cocaine users in the UK fell by a third. The party that had raged since the early 1990s was seemingly coming to an end. Then, like someone who doesn’t know when to call a cab, coke sat up, shook itself awake and sat back at the table. In the past five years, usage has recovered almost to its 2008 peak. The reasons behind this shift are hard to unpick, but they are also very simple.



The strength of the cocaine on UK streets has quadrupled



About a decade ago, most cocaine was, in reality, anything but cocaine. “It was 10-20 per cent pure. The rest of it was bulking agents,” says Steve Rolles, a policy analyst for drugs reform charity Transform. As with any consumer good, people drifted away when coke stopped offering much bang for their buck. Then-legal highs such as mephedrone and Spice crept into the market. In response to these interlopers, cocaine rebranded. Dealers lowered their prices and stopped over-diluting their product. In recent years, the strength of the cocaine on UK streets has quadrupled. “Uncut, effectively pure cocaine began appearing on the market,” says Rolles. And it found a receptive audience. “When cocaine started getting good again, people migrated back.”


Little White Lies


This recent enthusiasm is at odds with our purported rejection of other ways of getting messed up. We drink less than we used to, with millennials in particular turning their backs on booze in record numbers. And yet, cocaine use among 16-to-24-year-olds has doubled in the past five years. Harry Sumnall, a professor in substance use at Liverpool John Moores University and member of the UK Advisory Council on the Misuse of Drugs, isn’t too surprised. “Like many trends, drugs are subject to fashion and social norms,” he says. “If you look at other drug use, ecstasy is at its highest level since the early 2000s. LSD has gone up. Cannabis has gone up.”


Perhaps, some suggest, a minority of enthusiastic users is skewing the statistics. There will always be some young people who want to do drugs, and with cocaine now more potent and more affordable than it has been for decades, those who are tempted are diving in nostrils first. There are more teetotal young people, Sumnall concedes, but binge-drinking hasn’t yet been consigned to history. And because cocaine still has a comparatively niche user base, small increases in the number of people taking it will produce spikes in official reports.

Rolles suggests that part of cocaine’s attraction is that it appeals to the sensibilities of the current moment: it’s an ego-inflating drug that chimes with our self-obsessed, solipsistic world, just as it did in the 1980s. “Cocaine fits in with social media culture,” he says. “People are documenting their nights out more. With alcohol, you look bleary, staggering around. On ecstasy, you look like you’re on drugs. But you can take cocaine and it doesn’t show.”

Ironically, the rise of gym culture may also have its part to play. As more than one user pointed out to MH, cocaine is, in effect, carb- and calorie-free. “Beer makes you fat,” one said. “Besides, if I take coke, I don’t want a kebab at the end of the night, so I don’t gain weight. And often I don’t feel like shit, either. So, I can get up and go to the gym the next day.”


There was also a widespread view among an admittedly small and biased sample that cocaine wasn’t really that bad for you. The “scared-straight” approach to drugs education that these people endured at school didn’t seem to relate to their own experiences. They took it a few times but didn’t become addicts, so figured that the other horror stories probably weren’t true, either. “It’s horseshit,” says Ian. “From a health perspective, if you have to choose between the occasional line or being a man with a wine fridge, you should go for the class As.”

When this point of view is presented to Peter J Hamilton, who studies cocaine at the Icahn School of Medicine’s Nestler Lab in New York, he laughs. “Absolutely not. Alcohol is by no means good for you,” he says, “but cocaine is much riskier.” Long-term use is associated with a slew of mental health problems, especially depression. “But the health risks for recreational users also include the acute effects of the drug at the time of use – such as a spike in blood pressure, seizures, heart failure and stroke.” Your chance of a heart attack increases 24-fold in the hour after ingesting cocaine, when the drug sends the organ racing while constricting the arteries that supply it. In other words, it’s like putting your foot on the accelerator and the brakes at the same time.


Inherent Vice

Scaling these side effects according to frequency of use is not easy. Our bodies can react differently to the same substances. In this respect, every person who dabbles is rolling the dice. The likes of Craig, to whom cocaine had become a daily necessity, would undoubtedly experience some damage. But so could weekend users such as Ian. For most people, at least according to the statistics, cocaine is an irregular vice. The average powder cocaine user takes the drug less than 10 times a year, according to the Global Drug Survey, which maps substance abuse patterns in more than 30 countries. “Most people are using it in a non-problematic fashion,” says Sumnall. “Of young people who used cocaine in the past year, only half did so more frequently than once or twice. So, more people are using it, but they’re not increasing their use.”



Enemy Lines



As we talked one Friday afternoon earlier this year, Ian oscillated between his sofa and a mound of cocaine that his dealer had just deposited on his kitchen counter. His partner was out of town, and a friend was on his way. “He’s a coke friend,” Ian said. “When you see them, there’s an expectation. Offer them a coffee, or a glass of wine. Then, offer them a bump.”


As he stood next to the pile, holding a silver straw in one hand, he gestured with the other to the fridge behind him. “Everything in there is free range, organic, fair trade…” he said. “No sugar, nothing processed. It is, if you were to audit it, full of nothing but healthy things.” He laughed. “And yet here I am, snout down in a pile of chop. How undignified.”

Ian is aware of the hypocrisy of his drug use. It’s not just that it’s bad for him, but also that every gram he buys is inseparable from its criminal origins. Yet he doesn’t feel particularly responsible. “British weapons are killing civilians in Yemen. Thousands of people are 
killed by guns in America. Cocaine is not some uniquely evil thing.”

Tony Saggers, a 30-year veteran of British drug policing and the former head of drugs threat at the National Crime Agency, disagrees. “There’s more violence, crime and exploitation linked to the cocaine trade and funds from it than that of any other drug,” he says. Gangs that move cocaine use the same supply networks to smuggle firearms, or women into the sex trade. In producer countries, it is linked to tens of thousands of murders and wide-scale corruption.

The drug is grown almost exclusively in Peru, Bolivia and, increasingly, Colombia. After a dip at the start of the decade, Colombian cocaine production has exploded in the past few years. It’s an unexpected consequence of the government’s peace treaty with the leftist Revolutionary Armed Forces of Colombia (Farc), which, during its 50-year conflict against the state, taxed coca farmers for war funds. Now that Farc has hung up its AKs, narco-traffickers have taken its territory, increasing Colombia’s cocaine output by a third.



In the UK, this oversupply has been exploited largely by Albanian gangs, which set up in Britain during the Balkan Wars. These gangs have forged direct relationships with producer countries. With the middlemen cut out, they have been able to flood the market with stronger cocaine at lower prices. “It’s a conscious marketing strategy to make it popular again,” says Rolles. Consider, too, that while the cost of cocaine has fallen in the past decade, the price of a pint has gone up by a third, and house prices have increased by almost half. (As Ian puts it, “Everything’s so expensive now. So why not spend £80 on a couple of grams instead?”)

The new purity of cocaine means it contains fewer unknown nasties: dealers have been known to cut the drug with everything from dental anaesthetics and caffeine to cow dewormers that some studies hint might increase the drug’s addictive potential. But purer drugs aren’t inherently safer. “People continue to use the same amount as they used before, so they just end up getting a bigger hit,” says Adam Winstock, a consultant psychiatrist, addiction specialist and founder of the Global Drug Survey. “The truth is you’re more likely to lose control.”



Powder Keg


Cocaine is also killing people. Along with an increase in cocaine-related mental health hospital admissions, mortality rates have quadrupled over the past seven years – although it’s hard to tell whether it’s users of powder cocaine or crack (a derivative that can be smoked) who are dying. “When coroners do tests, the metabolites come up as the same thing,” says Karen Tyrell, from substance abuse charity Addaction. What is clear is that crack inspires far more people to seek help. “Problematic [powder] cocaine users often don’t present at treatment centres. If you’re out three nights in a row using cocaine in pubs and clubs, you might have one day off sick, then you’re back at work. You might not consider yourself a problematic user.”

Few people realise that, chemically speaking, the two are identical. “Crack and powder cocaine work in exactly the same way in the brain,” says Hamilton. In a healthy brain, dopamine is released when we do things that are evolutionarily advantageous – eating calorie-dense foods, having sex – stimulating our pleasure receptors. This dopamine should then be swiftly recycled, but cocaine binds to the proteins that control reuptake. Flooded with dopamine, the brain’s reward centres just keep firing, triggering a sense of euphoria. Hamilton likens it to a room full of sinks with running taps, and cocaine molecules are the plugs. Chewing coca leaf is comparable to adding them one at a time; the sinks fill slowly. Snort it, however, and you block every drain at once. The room floods.


There’s more violence, crime and exploitation linked to the cocaine trade and funds from it than that of any other drug



Yet it is not a drug that works the same way in every brain. It’s estimated that half of your propensity for substance abuse is dictated by your environment, while the other half is built into your DNA. “There are individuals who are inclined to abuse the drug, and there are others who are somewhat impervious, who can use it recreationally and not succumb to addiction,” says Hamilton. The trouble is that no one knows in which group they fall.

Even among recreational users, the line between dependency and a “casual” habit can be hard to discern. Most of the people who spoke to MH expressed some uncertainty about the extent to which they – or their friends – had their usage under control. “I’d like to do it less often,” one user told MH. “But when I’m out with my friends, and they’re all taking cocaine, I feel like I need it just to keep pace. It’s a bit ‘Go hard or go home’.”

Its ubiquity can also go some way to explaining the current lack of concern about both cocaine’s health implications and its ethical ones. There’s a principle in psychology called the bystander effect, in which the greater the number of people who witness an incident, the less likely each one is to intervene. Our sense of personal responsibility becomes diluted. In the same way, when cocaine is seemingly everywhere – in every bar, at every dinner party, or ordered at the tap of a touchscreen – it provides a certain reassurance. If no one else is concerned, why should I be?


Snow Warning

Craig, now 37, once felt that way, too. He first took cocaine when he was 20 and, for most of the following decade, it was an occasional treat. But by 30, he was drinking heavily, and cocaine had become a fixture of his days off. “I’d get excited about sniffing it,” he says. “‘When are you going to get it? Can I come and get it now?’ Then, when you’ve got it in your pocket, it’s just sitting there. I’d look for places to do it. I hated doing it in public, but I’d always find somewhere.”






Cocaine addiction is largely in the mind. After a decade of exposure, Craig’s brain would likely have developed dopamine-sensitive growths, called spines, which create deep, almost insurmountable cravings. The drug would also have fundamentally altered his prefrontal cortex, the area responsible for decision-making. As the primitive parts of his brain yearned for cocaine, his ability to assess its risk collapsed. “I’d start off lightly, with 3g. That would last an hour and, once I’d got it in me, I’d want more and more. I could spend £800 a night quite easily.”

It doesn’t help that, according to the Global Drug Survey, many users can get cocaine delivered more quickly than a pizza. “You don’t have to go through much planning, and that is really important for a drug like cocaine,” Winstock says. “It’s a spontaneous purchase.”

Gradually, Craig began to lose control, drinking more, doing more cocaine, until one night, with 16 pints and a few grams inside him, he decided to kill himself. “I didn’t have a way out, and that was my way out,” he says. After an hour willing himself to jump – “My brain was saying, ‘Do it!’ but my legs wouldn’t move” – a fisherman spotted him and called the police, who talked him down. With the help of the charity Addaction, he has stayed clean. “I never saw a light at the end of the tunnel at all. But now I’m on a bigger and better path.”

Ian, perhaps, does not have a genetic predisposition for addiction. But that doesn’t mean he is without his share of conflicts. In the spirit of the New Year, he considered quitting the habit in January, but decided it wasn’t for him. “I think you have to be motivated towards something else, not just away from drugs,” he says.

For now, he feels that he has a handle on his intake. He plans to cut down and do other things – such as paint a wall that, for a couple of years, cocaine has sapped him of the motivation to tackle. For the moment, though, that can wait. Today, a bump would be more fun.




Cannabis on trial



Cannabis on trial


How will the NHS conduct accurate trials of cannabis-based medicinal products when everyone has already tried cannabis? Dr David Horn, medical director at the Centre for Medicinal Cannabis, reports.


Until November 2018, cannabis was a Schedule 1 drug under the Misuse of Drugs Regulations 2001. This schedule defines its contents as “considered by the government to have no medicinal value.” Thus the medicinal properties of cannabis were overlooked by the NHS. Cannabis related substances, bar a couple of MHRA licensed drugs, therefore exempted from Schedule 1 but ascribed low clinical priority by NICE, were summarily ignored for medical use.


As Dame Sally Davies has testified to the Health Select Committee, following her review of reviews upon which the home secretary has relied, cannabidiol (CBD) is adequately proven to be of clinical use in Dravet’s and Lennox-Gastaut epilepsy syndromes. The status of CBD has always been outside of the Misuse of Drugs legislation, due to the fact it is not intoxicating.

CBD is classed as a novel food – it was permitted as a foodstuff by EFSA provided that the THC content was less than 0.2%. However, in January, EFSA updated its novel foods catalogue, and a food safety assessment is now required unless there is a successful objection to this change. However, products containing the ingredient can be found on shop shelves throughout the UK. What has turned things around in the medical establishment is relatively recent observational trial data.


Poorly controlled epilepsy occurs in approximately 20% of epilepsy in children, and is defined by resistance to treatment with at least two first line drugs, ketogenic diet and surgery where appropriate. Children may experience tens or even hundreds of fits per day, potentially an existential threat.


Cannabis-based medicinal products (CBMPs) with a 20:1 ratio of CBD to THC are shown in Israeli observational trials to be effective in treating 50% of these patients, who will experience 50% less fits. A further 25% will experience 75% cessation and 4% will have no fits at all. Given the THC level falls under the Misuse legislation, regulators have wisely now, by way of its rescheduling, stepped back to empower the medical establishment to deal with the situation, with a generous NIHR grant programme also being ordained.


Respite for UK medicine is granted due to the fact these open label observational trials (that tend commonly to exaggerate efficacy) demonstrate a signal, but do not of themselves turn data into knowledge. Though with pressure mounting to deal with the fallout of change in political stance towards cannabis (medicinal and recreational), the time has now come for randomised controlled trials – and the BPNA have these in current conception.


Nevertheless, public, political and medical attitudes towards the drug are evolving fast, and it seems we are late to the cannabis party. In a world of internet-enabled patients, medical tourism, and the threat of legalisation for recreational use spreading eastward across the Atlantic (driven by growing political necessity), time is short.


Already, impatient UK parents such as those of Teagan Appleby are travelling to the Netherlands to legally seek cannabis treatment for epilepsy, as many others already do from Germany. It is worth pointing out that it is potentially not in the interests of UK patients because they are likely to be excluded from any imminent UK trials on the basis of a requirement to remove the “signal noise” borne of pre-existing exposure. GPs might therefore advise parents appropriately against medical tourism, and well-meaning Patient Advocacy Groups might consider how they will support their now excluded patients who could remain so for many years as a result of their intervention. Given the developmental question hanging over THC, this is not likely to be resolved for an extended period.


However, a greater threat arises from recreational use. Recreational cannabis is far cheaper to produce and for the public to source than medical grade. This a substantial medical risk to patients due to the uncontrolled nature of production, exposure to dangerous contaminants such as heavy metals, aflatoxin, moulds, pesticides, and highly-variable batch cannabinoid content. As Canada is now finding out, it is extremely difficult to undertake clinical research now that there is wide access to CBMPs. Potentially every trial participant has already used cannabis.


Unless there is rapid expansion in UK cannabis research, patients who feel they could benefit from medicinal cannabis may well lose patience and take the matter into their own hands for issues of chronic pain, fibromyalgia, allodynia, insomnia, and anxiety. Patients are already “growing their own” and campaigning to be able to cultivate their cannabis due to the frustration they have at not being able to access CBMPs via the NHS – despite them being legal for six months.


Like Canada, the UK would find it equally difficult to conduct classical sense medical trials in this scenario. Without adequate trials, justification for NHS prescription of safe medical grade CBMPs may never become publicly funded. This could usher in deregulation as the only cost-viable alternative in the face of uncontrollable public demand. Alternatively, by rapidly responding to this research challenge now, before it is too late, the UK might well become uncontested leaders in this field with safe, affordable medical cannabis available upon NHS prescription.



Teenage cannabis addict who stamped on the head of a man vows to give up the drug



Teenage cannabis addict who stamped on the head of a man vows to give up the drug


He has reduced cannabis smoking and hopes to stop




A Stroud cannabis addict who stamped on the head of a man who had been “goading him for a fight” was back in court this week to confirm that he was working hard to give up the Class B drug.

Edward Krolikowski, 18, of Parliament Street, Stroud, appeared before Recorder Anna Midgely at Gloucester Crown Court on Tuesday when a probation officer confirmed that he had reduced his cannabis smoking and hoped to have stopped altogether by the end of next month.

Probation officer Ashley Joym said: “He has engaged positively with the service throughout this community order and now smokes cannabis just three or four times a week as opposed to his previous daily habit.”


The judge told the teenager: “I would like you to give a negative test on your next review, which is on June 25, but well done for the progress you have made so far.”

Krolikowski at a previous earing had admitted assaulting Liam Ballinger at the victim’s Stroud home on September 5 last year. He also admitted criminal damage to Mr Ballinger’s iPhone when he threw it over a balcony after the assaults.

He was made the subject of a 12-month community order with 20 rehabilitation activities and six months drug rehabilitation.

He was also ordered to pay £170 compensation for the damage to the phone.




Your message has been successfully sent.
Oops! Something went wrong.

Get in touch

If you wish to enquire about anything, or just say hi, please fill in the form opposite, or email us on:

Copyright 2020